Scott Goldberg, DDS
Oral and Maxillofacial Surgery · Melrose, MANPI 1457693772
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,601 of the $3,536 with a category attached, or 73.5%. Straumann USA LLC accounts for 73.9% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $1,867, more than ten times the $26 reported in 2019.
Across 34 payments — averaging $104.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Straumann USA LLC$3K
- Dentsply LLC$600
- Salvin Dental Specialties, Inc.$220
- Dentsply Sirona Inc$43
- Johnson & Johnson$35
- Zimmer Biomet$26
What the payments were for
- Speaking & faculty fees$63818%
- Food & beverage$2,60174%
- Education$2006%
- Gifts$973%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Straumann USA LLC | 27 | $2,612 |
| Dentsply LLC | 1 | $600 |
| Salvin Dental Specialties, Inc. | 1 | $220 |
| Dentsply Sirona Inc | 3 | $43 |
| Johnson & Johnson | 1 | $35 |
| Zimmer Biomet | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,536 in reported general payments places this provider in the 80th percentile of 247 oral and maxillofacial surgery providers in Massachusetts.
See all oral and maxillofacial surgery providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Chlorhexidine Gluconate | 164 | $812 |
| Amoxicillin | 137 | $552 |
| Dexamethasone | 19 | $476 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 66 | $217 |
| Clindamycin Hcl | 23 | $169 |
| Oxycodone Hcl | 12 | $48 |
| Naproxen | 11 | $24 |
Paid to pharmacies, not to this prescriber.
Other oral and maxillofacial surgery in Melrose
- Ilya GaribyanMelrose$6K
- William BontempiWestfield$93K
- Briana BurrisBoston$67K
- Cory ResnickBoston$65K
- David LustbaderQuincy$54K
- Daniel ChoiBoston$48K
- David ChangBoston$42K
- Miguel VidalBoston$25K
- Jose MarchenaPeabody$24K
- Timothy OsbornMedford$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.